clinical trial retatrutide of next-gen weight-loss drug brings it one step closer to FDA approval Retatrutide: Complete Triple Agonist Research

doi: 10.1016/j.jhep.2015.11.014

Pro tip Try a brief daily meditation

Cancer Care Using Modified COSMIN Methodology Thomas Porter 1 , Sabrina Figueiredo 1 1 George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :1072 Aims Real-world evidence (RWE) is increasingly relevant in oncology, yet robust tools for measuring cancer physicians attitudes toward RWE are lacking

The fat redistribution pattern that defines perimenopause, specifically abdominal accumulation, responds to lipolytic GH signaling in a way that caloric restriction alone does not produce